These amino acid positions in DRB1 have previously been shown to be associated with the risk of type 1 diabetes7 and rheumatoid arthritis5, suggesting that HLA-DRB1 effects on CPVL and antigen presentation may influence type 1 diabetes and rheumatoid arthritis risk. This evidence concerns the gene HLA-DRB1 and type 1 diabetes mellitus.